<DOC>
	<DOCNO>NCT02540460</DOCNO>
	<brief_summary>The purpose study investigate population pharmacokinetics LCB01-0371 multiple oral dose healthy male subject . To investigate safety , tolerability LCB01-0371 multiple oral dose healthy male subject .</brief_summary>
	<brief_title>Multiple Ascending Dose , Phase 1 Clinical Study LCB01-0371</brief_title>
	<detailed_description>Double blind , randomize , placebo control , multiple dose , dose escalation study</detailed_description>
	<criteria>1 . Healthy male 20 45 year age time screen 2 . Subjects body mass index ( BMI ) 20 kg/m2 27 kg/m2 time screen 3 . Agree continue use medically reliable dual contraception donate sperm 30th day study completion 4 . Capable give write informed consent , willing participate clinical trial , willing comply study requirement . 1 . History liver , kidney , alimentary , respiratory , musculoskeletal , endocrine , neuropsychiatric , hematooncologic , cardiovascular problem ( ) 2 . History gastrointestinal problem ( e.g . Crohn 's disease , gastrointestinal ulcer ) within 6 month possibly affect absorption clinical trial drug , history surgery ( except simple appendectomy herniotomy ) 3 . History hypersensitivity reaction history clinically significant hypersensitivity reaction LCB010371 class study drug ( linezolid ) drug include aspirin antibiotic 4 . History drug abuse positive result urine drug screen 5 . AST , ALT , rGT , bilirubin ( total ) value 1.5 time ULN</criteria>
	<gender>Male</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2015</verification_date>
</DOC>